Drug Profile
Research programme: CETP inhibitors - Bristol-Myers Squibb
Alternative Names: BMS-795311Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Small molecules
- Mechanism of Action Cholesterol ester transfer protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cardiovascular disorders